Will You Be Attending Experimental Biology 2014?

Apr 17 2014 Published by under ASPET, Blogging, Experimental Biology

The good folks at the American Society for Pharmacology and Experimental Therapeutics have seen fit to invite me to serve as an official blogger for the Experimental Biology 2014 meeting to be held in San Diego, CA, April 26-30. I will be joined in this effort by @katiesci who blogs at http://sicknessisfascinating.blogspot.com.

I would like to invite you, Dear Readers, to send me your presentation details, should you be attending this year. You can drop a note in the comments to this thread or send me an email (drugmnky at the google mail). I will try to stop by if it fits in my schedule and maybe blog it if I can understand what you do.

There may also be a meet up or two which revolves around either this community at the blog or my Twitter Tweeps. So stay in touch about that. If you are interested in such a thing and leave a comment, this may help to stimulate someone (say, me) to get off their behind and organize something.

Looking forward to seeing some of your science and to meeting some of you.

4 responses so far

  • Jonathan says:

    I'm on a panel talking about science policy careers on Sunday from 2:45-6 pm (iirc): http://experimentalbiology.org/2014/Program-Information/Society-Programs/ASBMB.aspx

    I would be very interested in a tweetup especially if it's somewhere with beer. Saturday is better for me than Sunday but my flight on Sunday is ~10 pm so I could still make it on Sunday even after my talk.

    Of course, that presupposes people want to meet me 😉

  • Bill F. says:

    The Arkansas Mafia will be presenting a symposium on synthetic cannabinoids on Wednesday from 9:30 AM – 12:00 PM. We'll be competing with the Ray Fuller symposium, which is lame. Anyway, here's the details:

    Scientists versus street chemists: The toxicity of designer marijuana
    San Diego Convention Center, Room 3
    9:30 AM – 12:00 PM

    Supported by funding from Cayman Chemical Company
    Sponsored by the Divisions for Toxicology; Behavioral Pharmacology; Integrative Systems, Translational and Clinical Pharmacology; and Neuropharmacology

    Chairs: Laura P. James, Arkansas Children's Hosp. and Jeffery H. Moran, Univ. of Arkansas for Med. Sciences

    An analytical chemist's approach to public health problems
    Jeffery H. Moran, Arkansas Dept. of Health

    Atypical in vitro pharmacodynamic and metabolic characteristics of K2 synthetic cannabinoids: Keys to toxicity?
    Paul L. Prather, Univ. of Arkansas for Med. Sciences

    Pharmacodynamic and pharmacokinetic factors impacting the in vivo pharmacology and toxicology of K2 synthetic marijuana
    William E. Fantegrossi, Univ. of Arkansas for Med. Sciences

    Clinical and unexplained idiosyncratic toxicity of K2 exposure
    Genevieve L. Buser, Oregon Hlth. Authority

    Junior Speaker: Functional Consequences of Synthetic Cannabinoid Metabolites and CYP2C9 Polymorphisms
    Catherine Allen, Univ. of Central Arkansas

  • drugmonkey says:

    Thanks for the head's up, Bill. We love discussing the fake weed around these parts.

  • katiesci says:

    Thanks for the shoutout! I've lined up some cool research to blog about.

    I'd be interested in a tweet up . I don't get in until Sunday morning.

    I'll likely tweet about my poster location as a #disappearingtweet the day of. I'll tag you in it in case you want to stop by.

Leave a Reply